For example, the authors recently found that B-type natriuretic peptide inhibits angiotensin II-induced PASMC proliferation and migration via the cGMP/PKG pathway, which might show therapeutic potential for PAH therapy [29]. This evidence concerns the gene AGT and pulmonary arterial hypertension.